Relative Replication Capacity and Selective Advantage Profiles of Protease Inhibitor-Resistant Hepatitis C Virus (HCV) NS3 Protease Mutants in the HCV Genotype 1b Replicon System

Benzer Materyaller

• In Vitro and In Vivo Antiviral Activity and Resistance Profile of the Hepatitis C Virus NS3/4A Protease Inhibitor ABT-450
  Yazar:: Pilot-Matias, Tami, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• Identification and Structural Characterization of I84C and I84A Mutations That Are Associated with High-Level Resistance to Human Immunodeficiency Virus Protease Inhibitors and Impair Viral Replication
  Yazar:: Mo, Hongmei, ve diğerleri
  Baskı/Yayın Bilgisi: (2007)
• VX-950, a Novel Hepatitis C Virus (HCV) NS3-4A Protease Inhibitor, Exhibits Potent Antiviral Activities in HCV Replicon Cells
  Yazar:: Lin, Kai, ve diğerleri
  Baskı/Yayın Bilgisi: (2006)
• The Combination of Grazoprevir, a Hepatitis C Virus (HCV) NS3/4A Protease Inhibitor, and Elbasvir, an HCV NS5A Inhibitor, Demonstrates a High Genetic Barrier to Resistance in HCV Genotype 1a Replicons
  Yazar:: Lahser, Frederick C., ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• Evolution of Resistant M414T Mutants among Hepatitis C Virus Replicon Cells Treated with Polymerase Inhibitor A-782759
  Yazar:: Lu, Liangjun, ve diğerleri
  Baskı/Yayın Bilgisi: (2007)